Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-12 4:06 pm Purchase | 2022-10-12 | 13D | Health Sciences Acquisitions Corporation 2 HSAQ | RTW INVESTMENTS LP | 1,000,000 8.900% | 1,000,000 (New Position) | Filing History |
| 2022-10-11 4:30 pm Purchase | 2022-10-06 | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW INVESTMENTS LP | 17,628,567 24.400% | 1,355,932 (+8.33%) | Filing History |
| 2022-10-06 4:30 pm Sale | 2022-10-04 | 13D | Landos Biopharma, Inc. LABP | RTW INVESTMENTS LP | 365,072 9.070% | -62,500 (-14.62%) | Filing History |
| 2022-09-21 09:00 am Unchanged | 2022-09-19 | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW INVESTMENTS LP | 16,272,635 24.600% | 0 (Unchanged) | Filing History |
| 2022-09-21 09:00 am Purchase | 2022-09-19 | 13D | Renovacor, Inc. RCOR | RTW INVESTMENTS LP | 3,350,803 19.000% | 353,263 (+11.79%) | Filing History |
| 2022-02-14 09:36 am Sale | 2021-12-31 | 13G | Arbutus Biopharma Corporation ABUS | RTW INVESTMENTS LP | 2,504,493 1.700% | -3,473,862 (-58.11%) | Filing History |
| 2022-02-14 09:35 am Sale | 2021-12-31 | 13G | Agenus Inc. AGEN | RTW INVESTMENTS LP | 298,991 2.300% | -356,465 (-54.38%) | Filing History |
| 2022-02-14 09:33 am Purchase | 2021-12-31 | 13G | Science 37 Holdings, Inc. SNCE | RTW INVESTMENTS LP | 198,750 3.500% | 198,750 (New Position) | Filing History |
| 2022-02-14 09:32 am Sale | 2021-12-31 | 13G | Vincerx Pharma, Inc. VINC | RTW INVESTMENTS LP | 37,062 3.500% | -438 (-1.17%) | Filing History |
| 2022-02-14 09:31 am Purchase | 2021-12-31 | 13G | C4 Therapeutics, Inc. CCCC | RTW INVESTMENTS LP | 2,494,965 5.100% | 2,494,965 (New Position) | Filing History |
| 2022-02-14 09:29 am Purchase | 2021-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | RTW INVESTMENTS LP | 2,458,750 6.000% | 2,458,750 (New Position) | Filing History |
| 2022-02-14 09:26 am Purchase | 2021-12-31 | 13G | La Jolla Pharmaceutical Company LJPC | RTW INVESTMENTS LP | 2,590,932 9.300% | 193,554 (+8.07%) | Filing History |
| 2022-02-14 08:58 am Purchase | 2021-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | RTW INVESTMENTS LP | 6,029,700 9.200% | 161,374 (+2.75%) | Filing History |
| 2022-02-14 08:56 am Sale | 2021-12-31 | 13G | Exagen Inc. XGN | RTW INVESTMENTS LP | 821,414 5.100% | -428,717 (-34.29%) | Filing History |
| 2022-02-14 08:55 am Purchase | 2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | RTW INVESTMENTS LP | 2,863,198 5.600% | 2,863,198 (New Position) | Filing History |
| 2022-02-14 08:53 am Purchase | 2021-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN | RTW INVESTMENTS LP | 406,250 6.800% | 406,250 (New Position) | Filing History |
| 2022-02-14 08:51 am Purchase | 2021-12-31 | 13G | Pyxis Oncology, Inc. PYXS | RTW INVESTMENTS LP | 2,120,760 6.500% | 2,120,760 (New Position) | Filing History |
| 2022-02-14 08:50 am Purchase | 2021-12-31 | 13G | MacroGenics, Inc. MGNX | RTW INVESTMENTS LP | 3,975,554 6.500% | 3,975,554 (New Position) | Filing History |
| 2022-02-14 08:48 am Purchase | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | RTW INVESTMENTS LP | 755,482 7.700% | 32,745 (+4.53%) | Filing History |
| 2022-02-14 08:47 am Purchase | 2021-12-31 | 13G | CUTERA INC CUTRQ | RTW INVESTMENTS LP | 1,397,063 7.800% | 21,400 (+1.56%) | Filing History |